Hypereosinophilic syndrome with hepatobiliary masses and obstructive jaundice

Annals of Allergy, Asthma and Immunology

Volumn 94, Issue 1, 2005, Pages 25-28

  Reyes, Maria ^a   Abraham, Christina ^a   Abedi, Mahmood ^b   Carucci, Laura R ^c   Schwartz, Lawrence B ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; IRON; PREDNISONE;

ABDOMINAL PAIN; ADULT; ARTICLE; BILE DUCT CARCINOMA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EOSINOPHILIA; FATIGUE; FEMALE; HEPATOBILIARY DISEASE; HUMAN; HYPEREOSINOPHILIC SYNDROME; OBSTRUCTIVE JAUNDICE; PRIORITY JOURNAL; WEIGHT REDUCTION;

ADULT; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPEREOSINOPHILIC SYNDROME; INTESTINAL DISEASES, PARASITIC; JAUNDICE, OBSTRUCTIVE; LIVER NEOPLASMS;

EID: 12344323510     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore). 1975;54:1-27.
2. Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH. NIH conference: the idiopathic hypereosinophilic syndrome: clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med. 1982;97:78-92.
3. Spry CJ. The hypereosinophilic syndrome: clinical features, laboratory findings and treatment. Allergy. 1982;37:539-551.
4. Cools J, DeAngelo DJ, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 2003;348:1201-1214.
5. Klion AD, Noel P, Akin C, et al. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood. 2003;101:4660-4666.
6. Kerstein MD, Sheahan DG, Gudjonsson B, Lewis J. Eosinophilic cholecystitis. Am J Gastroenterol. 1976;66:349-352.
7. Croffy B, Kopelman R, Kaplan M. Hypereosinophilic syndrome: association with chronic active hepatitis. Dig Dis Sci. 1988;33:233-239.
8. Delevaux I, Andre M, Chipponi J, Milesi-Lecat AM, Dechelotte P, Aumaitre O. A rare manifestation of idiopathic hypereosinophilic syndrome: sclerosing cholangitis. Dig Dis Sci. 2002;47: 148-151.
9. Rosengart TK, Rotterdam H, Ranson JH. Eosinophilic cholangitis: a self-limited cause of extrahepatic biliary obstruction. Am J Gastroenterol. 1990;85:582-585.
10. Butler TW, Feintuch TA, Caine WP Jr. Eosinophilic cholangitis, lymphadenopathy, and peripheral eosinophilia: a case report. Am J Gastroenterol. 1985;80:572-574.
11. Grauer L, Padilla VM III, Bouza L, Barkin JS. Eosinophilic sclerosing cholangitis associated with hypereosinophilic syndrome. Am J Gastroenterol. 1993;88:1764-1769.
12. Noyer CM, Coyle CM, Werner C, Dupouy-Camet J, Tanowitz HB, Wiitner M. Hypereosinophilia and liver mass in an immigrant. Am J Trop Med Hyg. 2002;66:774-776.